Investigational New Drug Submissions for Individualized Antisense Oligonucleotide Drug Products for Severely Debilitating or Life-Threatening Diseases: Chemistry, Manufacturing, and Controls Recommendations Guidance for Sponsor-Investigators

Clinical / Medical

Source: FDA Center for Drug Evaluation and Research - What's New - July 14, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news